EJCTS Click here to locate an Ethicon representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Jacques Jougon
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jougon, J.
Right arrow Articles by Velly, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jougon, J.
Right arrow Articles by Velly, J. F.
Related Collections
Right arrow Anesthesia
Right arrow Lung - cancer
Right arrow Lung - other

Eur J Cardiothorac Surg 2002;22:345-351
© 2002 Elsevier Science NL


Massive hemoptysis: what place for medical and surgical treatment

Jacques Jougona*, Michel Ballesterb, Frédéric Delcambrea, Tarun Mac Bridea, Philippe Valatc, Francis Gomezc, François Laurentd, Jean François Vellya,1

a Department of Thoracic Surgery, Haut-Lévêque Hospital, Bordeaux University Hospital, avenue de Magellan, 33604 Pessac, France
b Department of Ear-Nose and Throat and cervico-facial surgery, General Hospital, University Hospital, 21033 Dijon, France
c Department of Intensive Care Unit, Haut-Lévêque Hospital, Bordeaux University Hospital, avenue de Magellan, 33604 Pessac, France
d Department of Radiology, Haut-Lévêque Hospital, Bordeaux University Hospital, Avenue de Magellan, 33604 Pessac, France

Received 30 January 2002; received in revised form 19 May 2002; accepted 23 May 2002.

* Corresponding author. Service de Chirurgie Thoracique, Hôpital du Haut-Lévêque, 33604, Pessac, France. Tel.: +33-556555009; fax: +33-556555021
e-mail: jacques.jougon{at}chu-bordeaux.fr

Objective: The objective of the study was to define timing of surgical treatment in management of massive hemoptysis. Methods: We performed a retrospective review of all patients admitted for massive hemoptysis in the intensive care unit of our thoracic surgery department. Treatment was managed according to the patient's status, the etiology of bleeding, the findings of bronchoscopy and computed tomographic scan. Therapeutic measures available were medical treatment, tracheal intubation (single or double lumen tube), interventional endoscopy, arterial embolisation and surgical treatment. Results: Between September 1996 and December 2001, 43 patients were treated (nine females and 34 males with mean age of 54 years, range from 32 to 79). The mean red cell blood transfusion per patient was 1.57 Units. The patients were classified into three groups: Group 1, 11 patients were operated on immediately close to the bleeding crise (five pneumonectomy and six lobectomy); Group 2, five patients for whom operation was delayed from the 7th to the 22nd day after cessation of bleeding (five lobectomy); Group 3, 27 patients were treated by non-surgical methods (medical treatment, endobronchial treatment, percutaneous embolisation). Fifteen patients underwent an arterial embolization, which was complete in 13 cases. Among the five patients of group 2, cessation of bleeding was obtained by bronchial embolisation in four cases. Considering the whole series, 10 (23%) patients died: three (19%) patients in group 1, zero in group 2, seven (26%) in group 3. In two patients who were suffering from tumor necrosis, hemoptysis relapsed leading to death. Conclusion: Emergency thoracotomy for massive hemoptysis is at high risk. In case of bleeding from the arterial bronchial vessels, embolization may enable to postpone surgery and operate secondarily. In case of bleeding from the pulmonary vessels (tumor necrosis), surgical treatment must be immediate. An algorithm for management is proposed.

Key Words: Hemoptysis • Respiratory distress • Bronchial carcinoma • Tuberculosis • Bronchectasis • Bronchial arteries




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
H. C.N. Tien, M. R.C. Gough, R. Farrell, and J. Macdonald
Successful Use of Recombinant Activated Coagulation Factor VII in a Patient with Massive Hemoptysis From a Penetrating Thoracic Injury
Ann. Thorac. Surg., October 1, 2007; 84(4): 1373 - 1374.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Valipour, A. Kreuzer, H. Koller, W. Koessler, and O. C. Burghuber
Bronchoscopy-Guided Topical Hemostatic Tamponade Therapy for the Management of Life-Threatening Hemoptysis
Chest, June 1, 2005; 127(6): 2113 - 2118.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
A. Ayed
Pulmonary resection for massive hemoptysis of benign etiology
Eur. J. Cardiothorac. Surg., November 1, 2003; 24(5): 689 - 693.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
M. Metin, A. Turna, A. Sayar, and A. Gurses
Prompt surgery for massive hemoptysis: more acceptable than it was reported
Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 647 - 647.
[Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
J. Jougon, F. Delcambre, and J.-F. Velly
Reply to Metin et al.
Eur. J. Cardiothorac. Surg., April 1, 2003; 23(4): 648 - 648.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2002 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.